597 related articles for article (PubMed ID: 24603731)
21. Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors.
Cano H; Candela MJ; Lozano ML; Vicente V
Transfus Med; 2003 Oct; 13(5):259-66. PubMed ID: 14617336
[TBL] [Abstract][Full Text] [Related]
22. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
Bååth L; Widell A; Nordenfelt E
J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
[TBL] [Abstract][Full Text] [Related]
23. Indeterminate third-generation hepatitis C recombinant immunoblot assay and HCV RNA analysis: isolated reactivity against NS5 associated with HCV viraemia in clinical patients but not blood donors.
Cavazza S; Lagging M
Scand J Infect Dis; 2005; 37(6-7):488-92. PubMed ID: 16012009
[TBL] [Abstract][Full Text] [Related]
24. The clinical relevance of persistent recombinant immunoblot assay-indeterminate reactions: insights into the natural history of hepatitis C virus infection and implications for donor counseling.
Makuria AT; Raghuraman S; Burbelo PD; Cantilena CC; Allison RD; Gibble J; Rehermann B; Alter HJ
Transfusion; 2012 Sep; 52(9):1940-8. PubMed ID: 22304422
[TBL] [Abstract][Full Text] [Related]
25. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
[TBL] [Abstract][Full Text] [Related]
26. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
Engel PM; Dennin RH
Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
[TBL] [Abstract][Full Text] [Related]
27. New-generation RIBA hepatitis C strip immunoblot assays.
Polito AJ; DiNello RK; Quan S; Andrews W; Rose J; Lee F; Nelles M; Lee S
Beitr Infusionsther; 1992; 30():17-33. PubMed ID: 1284698
[TBL] [Abstract][Full Text] [Related]
28. Detection of HCV-RNA in the blood donor population of Yorkshire.
Reid JG
Br J Biomed Sci; 1994 Sep; 51(3):215-20. PubMed ID: 7881320
[TBL] [Abstract][Full Text] [Related]
29. Prospective study of the meaning of indeterminate results of the recombinant immunoblot assay for hepatitis C virus in blood donors.
Piro L; Solinas S; Luciani M; Casale A; Bighiani T; Santonocito D; Girelli G
Blood Transfus; 2008 Apr; 6(2):107-11. PubMed ID: 18946955
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the VIDAS Anti-HCV Assay for Detection of Hepatitis C Virus Infection.
Hyun J; Ko DH; Kang HJ; Whang DH; Cha YJ; Kim HS
Ann Lab Med; 2016 Nov; 36(6):550-4. PubMed ID: 27578508
[TBL] [Abstract][Full Text] [Related]
31. Determination of hepatitis C virus genotypes among blood donors in Ahvaz, Iran.
Farshadpour F; Makvandi M; Samarbafzadeh AR; Jalalifar MA
Indian J Med Microbiol; 2010; 28(1):54-6. PubMed ID: 20061766
[TBL] [Abstract][Full Text] [Related]
32. Long-term follow-up of and infectivity in blood donors with hepatitis C antibodies and persistently normal alanine aminotransferase levels.
Rossini A; Gazzola GB; Ravaggi A; Agostinelli E; Biasi L; Albertini A; Radaeli E; Cariani E
Transfusion; 1995 Feb; 35(2):108-11. PubMed ID: 7529954
[TBL] [Abstract][Full Text] [Related]
33. Markers of hepatitis C virus infection in Sardinian blood donors: relationship with alanine aminotransferase levels.
Lai ME; Mazzoleni AP; Farci P; Melis A; Porru A; Orgiana G; Arnone M; Balestrieri A
J Med Virol; 1993 Dec; 41(4):282-8. PubMed ID: 7508972
[TBL] [Abstract][Full Text] [Related]
34. Is it possible to diagnose acute hepatitis C virus (HCV) infection by a rising anti-HCV titre rather than by seroconversion?
Lu SN; Tung HD; Chen TM; Lee CM; Wang JH; Hung CH; Chen CH; Changchien CS
J Viral Hepat; 2004 Nov; 11(6):563-70. PubMed ID: 15500558
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis C virus (HCV) viremia in human immunodeficiency virus-seronegative and -seropositive patients with indeterminate HCV recombinant immunoblot assay.
Marcellin P; Martinot-Peignoux M; Elias A; Branger M; Courtois F; Level R; Erlinger S; Benhamou JP
J Infect Dis; 1994 Aug; 170(2):433-5. PubMed ID: 7518489
[TBL] [Abstract][Full Text] [Related]
36. [Interpretation of Ortho HCV Ab ELISA test results by chiron HCV recombinant immunoblot assay].
Yahagi N; Kitsugi K
Rinsho Byori; 1991 Jan; 39(1):26-33. PubMed ID: 1848912
[TBL] [Abstract][Full Text] [Related]
37. Characterization of differential antibody production against hepatitis C virus in different HCV infection status.
Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N
Virol J; 2016 Jun; 13():116. PubMed ID: 27357382
[TBL] [Abstract][Full Text] [Related]
38. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
[TBL] [Abstract][Full Text] [Related]
39. Analysis of sera indeterminate by Ortho-HCV RIBA-2 by using three confirmatory assays for anti-hepatitis C virus antibody.
Dussaix E; Charnaux N; Laurent-Puig P; Chopineau S; Laurian Y; Buffet C
J Clin Microbiol; 1994 Sep; 32(9):2071-5. PubMed ID: 7529247
[TBL] [Abstract][Full Text] [Related]
40. Serological diagnosis of hepatitis C virus in patients with liver disease in Saudi Arabia. Evaluation of antibody determination by recombinant immunoblot assays in relation to RNA detection by polymerase chain reaction.
Al-Ahdal MN; Kessie G
Diagn Microbiol Infect Dis; 1997 Mar; 27(3):69-73. PubMed ID: 9147007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
